Increase in resting heart rate over 10-year period linked with increased risk of heart disease death

December 20, 2011

CHICAGO - In a study that enrolled nearly 30,000 apparently healthy men and women, those who had an increase in their resting heart rate over a 10-year period had an increased risk of death from all causes and from ischemic heart disease, according to a study in the December 21 issue of JAMA.

Some evidence indicates that a high resting heart rate (RHR) is associated with increased cardiovascular disease and death in the general population, independent of conventional risk factors. However, whether changes in RHR over time influence the risk of death from ischemic heart disease (IHD) is not known, according to background information in the article.

Javaid Nauman, Ph.D., of the Norwegian University of Science and Technology, Trondheim, Norway, and colleagues conducted a study to examine the association of changes in RHR with the risk of death from IHD in a population-based group consisting of 13,499 men and 15,826 women without known cardiovascular disease. Resting heart rate was measured on two occasions around 10 years apart, with the second RHR measurement taking place between August 1995 and June 1997. There was follow-up until December 2008. A total of 60 participants were lost to follow-up due to emigration from Norway.

During an average of 12 years of follow-up, a total of 3,038 people died. Among all deaths, 975 were caused by cardiovascular disease and 388 were due to IHD. The researchers found that compared with participants with a RHR of less than 70 beats/min at both measurements, participants with a RHR of less than 70 beats/min at the first measurement but greater than 85 beats/min at the second measurement had a 90 percent increased risk of death from IHD. Participants with RHRs between 70 and 85 beats/min at the first measurement and greater than 85 beats/min at the second measurement had an 80 percent increased risk.

The researchers also found that the association of changes in RHR with all causes of death were similar to those observed for IHD mortality, but the estimates of effect were generally weaker.

Analysis also suggested that a decrease in RHR showed no general benefit in relation to IHD mortality.

"As expected from the good general health of the study participants, the observed moderate-to-strong increases in relative risk corresponded to small risk increases in absolute terms. However, it is not clear to what extent we can extrapolate our findings to less healthy individuals in whom the underlying risk is likely to be higher," the authors note.

"Our findings provide further support for the hypothesis that RHR may be an important prognostic marker for IHD and total mortality. Information on RHR and its time-related changes are easy to obtain and follow-up and may be useful in identifying asymptomatic people who could benefit from measures of primary prevention, but further study in this area is warranted."
-end-
(JAMA. 2011;306[23]:2579-2587. Available pre-embargo to the media at www.jamamedia.org)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.To contact corresponding author Ulrik Wisloff, Ph.D., email ulrik.wisloff@ntnu.no.

The JAMA Network Journals

Related Cardiovascular Disease Articles from Brightsurf:

Changes by income level in cardiovascular disease in US
Researchers examined changes in how common cardiovascular disease was in the highest-income earners compared with the rest of the population in the United States between 1999 and 2016.

Fighting cardiovascular disease with acne drug
Researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg and Stanford University have found the cause of dilated cardiomyopathy - a leading cause of heart failure - and identified a potential treatment for it: a drug already used to treat acne.

A talk with your GP may prevent cardiovascular disease
Having a general practitioner (GP) who is trained in motivational interviewing may reduce your risk of getting cardiovascular disease.

Dilemma of COVID-19, aging and cardiovascular disease
Whether individuals should continue to take angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the context of coronavirus disease 2019 (COVID-19) is discussed in this article.

Air pollution linked to dementia and cardiovascular disease
People continuously exposed to air pollution are at increased risk of dementia, especially if they also suffer from cardiovascular diseases, according to a study at Karolinska Institutet in Sweden published in the journal JAMA Neurology.

New insights into the effect of aging on cardiovascular disease
Aging adults are more likely to have - and die from - cardiovascular disease than their younger counterparts.

Premature death from cardiovascular disease
National data were used to examine changes from 2000 to 2015 in premature death (ages 25 to 64) from cardiovascular disease in the United States.

Ultrasound: The potential power for cardiovascular disease therapy
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Despite the ACA, millions of Americans with cardiovascular disease still can't get care
Cardiovascular disease (CVD) is the leading cause of death for Americans, yet millions with CVD or cardiovascular risk factors (CVRF) still can't access the care they need, even years after the implementation of the Affordable Care Act (ACA).

Excess weight and body fat cause cardiovascular disease
In the first Mendelian randomization study to look at this, researchers have found evidence that excess weight and body fat cause a range of heart and blood vessel diseases (rather than just being associated with it).

Read More: Cardiovascular Disease News and Cardiovascular Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.